Cure8 research brief
Why This Matters
Cardiovascular disease is an important nonintestinal complication for people with IBD; knowing if heart failure risk differs by IBD type could influence monitoring and care planning.
This study suggests ulcerative colitis hospitalizations had higher odds of concurrent heart failure while Crohn’s disease hospitalizations had lower odds in adjusted analyses.
Who Should Pay Attention
Adults with IBD (UC and CD), hospital clinicians, gastroenterology and cardiology teams, and researchers studying IBD comorbidities.
Study Snapshot
What To Know
This preprint analyzed a large U.S. hospital dataset to compare rates of concurrent heart failure (HF) in patients hospitalized with ulcerative colitis (UC) or Crohn’s disease (CD) versus matched non-IBD controls.
Using propensity-score matching and multivariable regression, the authors report that UC hospitalizations had slightly higher odds of concurrent HF, while CD hospitalizations had lower odds, after adjustment for common cardiovascular risk factors.
The study uses an administrative inpatient database (National Inpatient Sample), which captures diagnostic codes from hospital stays rather than detailed outpatient clinical measurements. That design allows large sample sizes but can miss disease duration, medication exposures, and imaging/test details that affect cardiovascular risk.
The article is a preprint/abstract-level report (structured content depth: abstract). The results are associations observed in hospitalized patients and do not prove that one IBD phenotype causes more or less heart failure. Clinical interpretation should consider individual risk factors and outpatient cardiology evaluation when appropriate.
Keep In Mind
Findings come from the U.S. National Inpatient Sample (hospital administrative data) and are presented in a preprint/abstract form. The dataset may lack outpatient data, medication exposures, and clinical verification of heart failure; results are associative, not causal.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.